ArticleObesity surgery2026
Excess-weight Metrics Misrepresent Weight Loss and All Weight Metrics Poorly Predict Early Glycemic Outcome After Metabolic and Bariatric Surgery.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMetabolic and bariatric surgery (MBS) outcomes are reported as weight loss, using percent total weight loss (%TWL), percent excess BMI loss (%EBMIL), or excess body-weight loss (%EBWL). We asked whether these metrics misrepresent weight loss and how well any of them predicts the early glycemic outcome at 6 months.
methodsUsing 2023 MBSAQIP data with 6-month follow-up, we studied sleeve gastrectomy and gastric bypass. We examined each metric's dependence on baseline BMI, then tested each as a predictor of HbA1c change and early glycemic response (HbA1c below 7.0% in patients uncontrolled at baseline), against a baseline-severity benchmark.
resultsOf 182,826 patients, 136,406 had a paired 6-month BMI and 27,517 had paired HbA1c, the remainder lost to follow-up. Only %TWL was independent of baseline BMI (rho - 0.016). %EBMIL and %EBWL were strongly baseline-dependent (rho - 0.458 and - 0.337), and %EBMIL exceeded 100%, an uninterpretable value, in 1.46% of patients. For early glycemic response, all metrics discriminated poorly (AUC 0.60 to 0.63). Baseline severity alone reached AUC 0.768. Weight and glycemic responses were discordant in 47.4% of patients (kappa 0.119, balanced accuracy 59.2%).
conclusionThe excess-weight metrics misrepresent how much weight was lost, most severely at low baseline BMI. No weight metric predicted the early glycemic outcome beyond what baseline severity already explained, and discrimination was weak for all of them. Glycemic and other metabolic outcomes should be measured directly rather than inferred from a weight metric, and prioritized in patients with type 2 diabetes. KEY POINTS: • Excess-weight metrics depend on baseline BMI and distort measured weight loss. • %EBMIL exceeded 100%, an uninterpretable value, in 1.46% of a national cohort. • No weight metric, including %TWL, predicted early glycemic response well. • Baseline metabolic severity outperformed every weight metric as a predictor.
Indexed as
Identifiers
42681258What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.